First National Bank Of Omaha Emergent Bio Solutions Inc. Transaction History

First National Bank Of Omaha

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2019 Jul 10, 2019	SELL	$39.92 - $53.86 $304,988 - $411,490	-7,640 Closed	0 $0
Q1 2019 May 01, 2019	SELL	$48.23 - $66.16 $2,893 - $3,969	-60 Reduced 0.78%	7,640 $386,000
Q4 2018 Jan 23, 2019	BUY	$55.63 - $73.24 $428,351 - $563,948	7,700 New	7,700 $456,000
Q4 2018 Jan 22, 2019	SELL	$55.63 - $73.24 $532,657 - $701,273	-9,575 Closed	0 $0
Q3 2018 Nov 05, 2018	SELL	$52.05 - $66.51 $1,301 - $1,662	-25 Reduced 0.26%	9,575 $630,000
Q2 2018 Jul 12, 2018	BUY	$48.33 - $55.64 $463,968 - $534,144	9,600 New	9,600 $485,000

158

33.8M

453K

931K

Ticker EBS
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 49,861,500
Market Cap $561M
Description
Emergent BioSolutions Inc., a life sciences company, focuses on the provision of preparedness and response solutions that address accidental, deliberate, and naturally occurring public health threats (PHTs) in the United States. The company's products address PHTs, which include chemical, biological, radiological, nuclear, and explosives; emergi...

Get notified when there are updates to the investment portfolio of First National Bank Of Omaha, based on Form 13F filings with the SEC.

Stay updated on First National Bank Of Omaha with notifications on news.